PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 

GTCbio

Press Release


Receive press releases from GTCbio: By Email RSS Feeds:
Nic Angell at Amgen to Speak at Protein Expression, Purification, Characterization Oct 23-24, 2014

Nic Angell, Principal Scientist, Process Development at Amgen to Speak at Protein Expression, Purification & Characterization Conference, October 23-24, 2014 in Boston, MA.

Boston, MA, July 05, 2014 --(PR.com)-- Nic Angell, Principal Scientist, Process Development at Amgen will give a presentation on “Molecule Assessment: Data Driven Optimization and Selection of Protein Therapeutic Candidates” at the Protein Expression, Purification & Characterization Conference to be held on October 23-24, 2014 in Boston, MA by GTCbio.

The Protein Expression, Purification & Characterization Conference will focus on the expression of difficult proteins, new methods of purification, extended characterization of production cell lines, the production of reagents for biologic programs, and analytical tools and computational methods. For more information, please visit www.gtcbio.com/proteinexpression

This conference is part of the larger Protein Discovery Summit 2014, which consists of three additional parallel co-located conferences:

2nd Protein-Protein Interaction
This conference will cover novel techniques, new algorithms and databases for PPIs, and potential druggable sites for disrupting protein-protein interactions.

2nd Antibody & Protein Therapeutics
This conference will present data and case studies on key topics such as antibody drug conjugates, bispecific antibodies and overcoming the blood-brain barrier.

3rd Protein Kinases & Drug Design
This conference will focus on discussions of how to overcome the many hurdles and answer exciting key questions for the successful development of new drugs, and targeting kinase signaling. Experts will also share their positive and negative experiences on how predictive preclinical models are with clinical efficacy and toxicology.
Contact Information
GTCbio
Kristen Starkey
626-256-6405
Contact
http://www.gtcbio.com
635 W. Foothill Blvd.
Monrovia, CA 91016
fax: 626-466-4433

Click here to view the list of recent Press Releases from GTCbio
Promote Your Business